Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Moffitt Cancer Center, Shands, UF to partner to improve cancer care

William S. Dalton, president/CEO and director of Tampa-based Moffitt Cancer Center (left, seated); UF President J. Bernard Machen and Shands HealthCare CEO Tim Goldfarb sign documents sealing a new cooperative agreement between their organizations. Watching the process are, from left, UF College of Medicine Dean Bruce Kone; H. Lee Moffitt, a former state senator and founder of Moffitt Cancer Center; and former U.S. Sen. Connie Mack, chair of the Moffitt Board of Directors. (Photo by Sarah Kiewel/University of Florida)

Michelle Foley, Moffitt Cancer Center

Michelle.Foley@moffitt.org

(813) 745-1505

Kim Jamerson, Shands HealthCare

jamerk@shands.ufl.edu

(352) 265-0373

Tom Fortner, UF College of Medicine

tfortner@ufl.edu

352-273-5814

Moffitt – Shands HealthCare – University of Florida Q & A

Moffitt Cancer Center, Shands Healthcare and University of Florida fact sheet

Moffitt Cancer Center, Shands HealthCare and the University of Florida announced today that they will work together to develop world-class programs in cancer care, research and prevention.

The partnership, which will extend Moffitt's innovative model of comprehensive patient care to UF and Shands cancer programs, was outlined at a joint news conference in UF's new Cancer-Genetics Research Complex.

"As a statewide resource for cancer research and treatment, Moffitt seeks to foster relationships such as these to maximize the state's investment in addressing cancer," said Dr. William S. Dalton, president/CEO and center director of Tampa-based Moffitt. "We feel this partnership will enhance Florida's national and international reputation in cancer care and research, and ultimately contribute to improving the overall standard of cancer care in Florida and increase the state's profile in cancer care and research in the state and beyond."

Under the arrangement, crafted through extensive discussions between Dalton, UF College of Medicine Dean Bruce Kone, Shands HealthCare CEO Tim Goldfarb and other leaders, the parties will look for opportunities to collaborate across the spectrum of patient care, research and educational activities. The participants signed a memorandum of understanding at the news conference.

"We're looking for synergies," Kone said. "Our efforts will leverage their best assets and our best assets to deliver world-class care and discovery."

As part of this collaboration, Moffitt's Total Cancer Care, or TCC, model and approach to a cancer patient's life journey will be integrated with the cancer program at Shands at UF, the academic medical center in Gainesville, renowned for its pioneering work in such areas as bone marrow transplantation and radiosurgery.

The TCC model is widely admired for its emphasis on quality improvement, the needs of surviving family members, and tissue and data collection for the purpose of tailoring therapies for individual patients, Kone said.

This alliance comes 18 months after of the opening of the Cancer-Genetics Research Complex on the UF campus. Additionally, Shands at UF is preparing for the completion of its $388-million, 500,000-square-foot cancer hospital in 2009. Cancer patients treated there will gain access to state-of-the-art therapies in a comfortable, healing environment.

Goldfarb said he especially likes the arrangement because it is "additive, not exclusive."

"This partnership doesn't disturb any relationship that our organizations have with other parties, in fact we welcome others to join us," Goldfarb said. "Through this alliance, we are uniting our intellectual, technological and scientific resources to truly lead cancer care for the benefit of Florida residents. Our impact together will be outstanding. This is an exciting day for people throughout our region."

In addition to implementing the TCC initiative, initial collaborations will include joint research, co-authored scientific publications, joint recruitment and philanthropy.

Working with the National Cancer Institute, Moffitt will seek to integrate the UF and Shands cancer program into Moffitt's NCI comprehensive cancer center designation, held by only 39 cancer centers nationwide. Inclusion should give UF scientists more opportunities at garnering NCI grants for collaborative projects with Moffitt investigators, Kone said. It also will give UF and Shands patients' better access to large-scale clinical trials of new therapies.

UF President Bernie Machen expressed his optimism about the progress made thus far.

"This collaboration has the real potential to have a major impact on every Florida citizen, because cancer touches all of us," he said. "Clearly this is just the beginning and a great deal of work is ahead of us, but the spirit of collaboration that has gotten us to this point is practically unheard of and it bodes well for the future of these efforts."

An archive of the news conference is now available at http://streaming.video.ufl.edu/~video/20080123-pressconference.asx

For the media

Media contact

Matt Walker
Media Relations Coordinator
mwal0013@shands.ufl.edu (352) 265-8395